SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy https://www.medrxiv.org/content/10.1101/2023.06.23.23288598
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.